Kim Jae-Yong, Kim Seong-Min, Kim Suk-Jeong, Lee Eun-Young, Kim Jae-Ryong, Cho Kyung-Hyun
Department of Medical Biotechnology, Yeungnam University, Gyeongsan 712-749, Republic of Korea.
Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, Daegu 705-717, Republic of Korea.
Int J Mol Med. 2017 Apr;39(4):889-899. doi: 10.3892/ijmm.2017.2907. Epub 2017 Feb 24.
It is well-known that policosanol can improve serum lipid profiles, although the physiological mechanism is still unknown. Here, we investigated functional and structural changes in lipoproteins after consumption of policosanol. To investigate the physiological effect of policosanol, we analyzed serum parameters in young non-smoker (YN; n=7, 24.0±2.4 years), young smoker (YS; n=7, 26.3±1.5 years), and middle-aged subjects (MN; n=11, 52.5±9.8 years) who consumed policosanol daily (10 mg/day) for 8 weeks. After 8 weeks, systolic blood pressure was significantly lowered to 4% (7 mmHg, p=0.022) from initial levels in the YS and MN groups. Moisture content of facial skin increased up to 38 and 18% from initial levels in the YS and MN groups, respectively. Serum triglyceride (TG) levels decreased to 28 and 26% from initial levels in the YN and MN groups, respectively. The percentage of high-density lipoprotein-cholesterol (HDL-C) in total cholesterol was elevated in all subjects (YN, 36%; YS, 35%; MN, 8%) after 8 weeks of policosanol consumption. All groups showed a reduction in serum glucose and uric acid levels. Serum cholesteryl ester transfer protein (CETP) activity was significantly diminished up to 21 and 32% from initial levels in the YN and MN groups, respectively. After 8 weeks, oxidation of the low-density lipoprotein fraction was markedly reduced accompanied by decreased apolipoprotein B (apoB) fragmentation. In the HDL fraction, paraoxonase activity was elevated by 17% along with elevation of apoA-I and cholesterol contents. Electron microscopy revealed that the size and number of HDL particles increased after 8 weeks, and the YS group showed a 2-fold increase in particle size. Daily consumption of policosanol for 8 weeks resulted in lowered blood pressure, reduced serum TG level and CETP activity, and elevated HDL-C contents. These functional enhancements of HDL can prevent and/or attenuate aging-related diseases, hypertension, diabetes and coronary heart disease.
众所周知, policosanol可改善血脂水平,但其生理机制仍不清楚。在此,我们研究了服用policosanol后脂蛋白的功能和结构变化。为了研究policosanol的生理作用,我们分析了每天服用policosanol(10毫克/天)8周的年轻不吸烟者(YN;n = 7,24.0±2.4岁)、年轻吸烟者(YS;n = 7,26.3±1.5岁)和中年受试者(MN;n = 11,52.5±9.8岁)的血清参数。8周后,YS组和MN组的收缩压从初始水平显著降低了4%(7毫米汞柱,p = 0.022)。YS组和MN组面部皮肤的水分含量分别比初始水平增加了38%和18%。YN组和MN组的血清甘油三酯(TG)水平分别比初始水平降低了28%和26%。服用policosanol 8周后,所有受试者(YN组为36%;YS组为35%;MN组为8%)总胆固醇中高密度脂蛋白胆固醇(HDL-C)的百分比均有所升高。所有组的血清葡萄糖和尿酸水平均降低。YN组和MN组的血清胆固醇酯转移蛋白(CETP)活性分别比初始水平显著降低了21%和32%。8周后,低密度脂蛋白部分的氧化明显减少,同时载脂蛋白B(apoB)片段化减少。在HDL部分,对氧磷酶活性升高了17%,同时apoA-I和胆固醇含量升高。电子显微镜显示,8周后HDL颗粒的大小和数量增加,YS组的颗粒大小增加了2倍。每天服用policosanol 8周可导致血压降低、血清TG水平和CETP活性降低以及HDL-C含量升高。HDL的这些功能增强可预防和/或减轻与衰老相关的疾病、高血压、糖尿病和冠心病。